Skip to content

Effect of acupuncture for type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Li et al. · Postgraduate Medical Journal · 2026

📊Meta-analysis of RCTs👥n=1479 participantsHigh clinical impact

Evidence Level

MODERATE
78/ 100
Quality
4/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

To evaluate the effect of acupuncture on blood glucose indicators related to type 2 diabetes

👥

WHO

1,479 patients with type 2 diabetes mellitus across 20 randomized clinical trials

⏱️

DURATION

Studies ranged from 15 days to 15 weeks of treatment

📍

POINTS

Head, trunk, and limb points; primarily four-limb points and trunk points

🔬 Study Design

1479participants
randomization

Acupuncture

n=744

Traditional Chinese acupuncture or electroacupuncture

Control

n=735

Usual care without acupuncture

⏱️ Duration: 15 days to 15 weeks

📊 Results in numbers

SMD: -0.52 (95% CI: -0.91 to -0.13)

Reduction in fasting blood glucose

SMD: -0.76 (95% CI: -1.24 to -0.27)

Reduction in glycated hemoglobin

SMD: -0.69 (95% CI: -1.00 to -0.39)

Reduction in 2-hour postprandial blood glucose

SMD: -1.72 (95% CI: -2.57 to -0.86)

Improvement in insulin resistance

📊 Outcome Comparison

Reduction in fasting blood glucose (SMD)

Acupuncture
-0.52
Control
0

Reduction in glycated hemoglobin (SMD)

Acupuncture
-0.76
Control
0
💬 What does this mean for you?

This study shows that acupuncture can be an effective complement to conventional treatment for type 2 diabetes, helping to reduce blood sugar levels and improve insulin resistance. Acupuncture demonstrated significant benefits when used alongside traditional diabetes medications.

📝

Article summary

Plain-language narrative summary

This rigorous meta-analysis examined the effect of acupuncture in the treatment of type 2 diabetes mellitus (T2DM), a chronic condition characterized by elevated blood glucose levels due to insulin resistance and impaired insulin secretion. The study included 20 randomized controlled trials with 1,479 patients, representing the most comprehensive analysis available on this topic to date. The research was conducted following rigorous protocols, including a search across four major databases and advanced statistical analysis with prediction intervals and the Hartung-Knapp adjustment to correct for between-study heterogeneity. The results demonstrated that acupuncture produced significant improvements in multiple markers of glycemic control.

Fasting blood glucose showed a significant reduction (SMD: -0.52; 95% CI: -0.91 to -0.13; P=0.009), as did glycated hemoglobin HbA1c (SMD: -0.76; 95% CI: -1.24 to -0.27; P=0.002), which is considered the gold standard for evaluating long-term glycemic control. The 2-hour postprandial blood glucose also showed substantial improvement (SMD: -0.69; 95% CI: -1.00 to -0.39; P<0.00001). Particularly impressive was the reduction in the HOMA-IR index (SMD: -1.72; 95% CI: -2.57 to -0.86; P<0.0001), indicating significant improvement in insulin resistance, a central aspect of T2DM pathophysiology. Interestingly, insulin levels did not show significant changes, suggesting that acupuncture acts primarily by improving insulin sensitivity rather than increasing its production.

The acupuncture techniques used included traditional Chinese acupuncture, electroacupuncture, and acupoint catgut embedding, with points located primarily on the head, trunk, and limbs. Protocols ranged from 15 days to 15 weeks of treatment, with sessions of 20 to 30 minutes. Subgroup analysis did not identify specific sources of heterogeneity, suggesting that the benefits are consistent regardless of the specific protocols used. From a clinical standpoint, these findings are highly relevant, as conventional T2DM treatment faces significant challenges, including medication side effects, difficulties in achieving personalized glycemic targets, and concerns about the long-term sustainability of pharmacological treatment.

Acupuncture emerges as a promising complementary therapy, offering benefits without the significant adverse effects associated with many medications. The safety of acupuncture, as reported in the included studies, was excellent, with only mild adverse events reported. This reinforces its potential as a noninvasive and cost-effective therapeutic option. The proposed mechanisms for the effects of acupuncture include modulation of vagus nerve activity, improvement in glucose uptake by the liver and skeletal muscles, and reduction of inflammatory responses.

Experimental studies suggest that stimulation of acupoints can activate cellular signaling pathways that improve glucose metabolism and reduce insulin resistance.

Strengths

  • 1Rigorous analysis with 20 RCTs and 1,479 participants
  • 2Use of prediction intervals and Hartung-Knapp adjustment
  • 3Comprehensive evaluation of multiple glycemic markers
  • 4Systematic search across multiple databases
⚠️

Limitations

  • 1High heterogeneity between studies (I²>75% in some outcomes)
  • 2Most studies conducted in Asian countries
  • 3Inherent difficulty in blinding for acupuncture interventions
  • 4Variability in the acupuncture protocols used
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

T2DM remains one of the most prevalent and complex chronic conditions to manage in our practice, especially in patients who do not reach adequate glycemic targets despite polypharmacy or who present intolerance to agents such as metformin, sulfonylureas, and glinides. This meta-analysis, by consolidating 20 RCTs with 1,479 patients, provides a solid quantitative basis for positioning acupuncture as an adjunct to conventional treatment. The documented benefits in fasting blood glucose, HbA1c, and 2-hour postprandial blood glucose cover exactly the outcomes we monitor in clinic. The reduction in insulin resistance measured by HOMA-IR is particularly relevant in the context of patients with metabolic syndrome, in whom peripheral insulin sensitivity is the central therapeutic target. Acupuncture therefore emerges as a concrete complementary option for clinicians seeking to broaden the therapeutic arsenal beyond pharmacological agents.

Notable Findings

The most noteworthy finding of this meta-analysis is the magnitude of the effect on HOMA-IR (SMD: -1.72; 95% CI: -2.57 to -0.86), considerably greater than the effects on the other glycemic markers evaluated. This gradient suggests that acupuncture acts primarily on insulin resistance — the core pathophysiologic mechanism of T2DM — and not on the pancreatic beta cell, given that circulating insulin levels did not change significantly. From a mechanistic standpoint, this is consistent with experimental evidence indicating vagal activation and modulation of inflammatory and metabolic pathways in the liver and muscles by acupoint stimulation. The consistency of the effects on HbA1c (SMD: -0.76) indicates sustained clinical impact across the weeks of treatment, not merely a transient variation in blood glucose.

From My Experience

In my practice, I have been incorporating acupuncture into the management of type 2 diabetic patients with unsatisfactory glycemic control for more than a decade, always in conjunction with the attending endocrinologist. The profile that responds best, in my observation, is the patient with overweight, predominant insulin resistance, and associated metabolic syndrome — exactly the subgroup that the HOMA-IR in this meta-analysis would most represent. I usually observe initial signs of glycemic improvement between the fourth and sixth session, with stabilization around the twelfth session; from then on, we begin to space appointments to biweekly or monthly maintenance. I combine electroacupuncture at points such as ST-36, SP-6, SP-9, and CV-12 with nutritional guidance and prescribed aerobic exercise, since the synergy with physical activity on muscle glucose uptake is clinically remarkable. I do not indicate acupuncture as monotherapy in patients with HbA1c above 9%, where intensive pharmacological management is non-negotiable; in these cases, acupuncture is added after initial stabilization. The results of this meta-analysis are consistent with what we have routinely observed in our service.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Postgraduate Medical Journal · 2026

DOI: 10.1093/postmj/qgaf132

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.